Beam Therapeutics BEAM Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Beam Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's quick ratio?
- Beam Therapeutics (BEAM) reported quick ratio of 17× in Q1 2026.
- How has Beam Therapeutics's quick ratio changed year-over-year?
- Beam Therapeutics's quick ratio increased by 92.8% year-over-year, from 8.8× to 17×.
- What is the long-term trend for Beam Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Beam Therapeutics's quick ratio has grown at a 34.1% compound annual growth rate (CAGR), from 3× to 13.1×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.